Nortriptyline Hydrochloride Capsule
Product Images NDC 51672-4002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nortriptyline Hydrochloride (NDC 51672-4002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nortriptyline 01)

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
This seems to be a description of a medication with the NDC code 51672-4001-1, containing capsules with dosage information available in the package insert. The medication should be stored at 20-25°C (68-77°F) and dispensed in a container with a child-resistant closure. The capsules are equivalent to M and are distributed by Taro Pharmaceuticals. The label contains a trademark registration statement and the code 79691-0317-3.*
FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Principal Display Panel (25 mg Capsule Bottle Label)
Each capsule of this medication contains Nortriptyline HCl, which is a type of medicine used to treat depression. The capsules are available in the form of 00 capsules and should be stored at controlled room temperature. The usual dosage is mentioned in the package insert. The medication is distributed by Taro Pharmaceuticals USA, Inc. and should be kept in a safe place. No additional information is available from the given text.*
FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Principal Display Panel (50 mg Capsule Bottle Label)
This text appears to be a description of a medication called Nortriptyline HCI. The medication is packaged in capsules, with each capsule containing an unspecified amount of Nortriptyline. The suggested dosage and prescription information are available in the package insert. The medication is manufactured by Taro Pharmaceutical Industries, located in Haifa Bay, Israel. The product should be stored at a controlled room temperature and kept away from children.*
FDA Label Image

Principal Display Panel (75 mg Capsule Bottle Label)

Principal Display Panel (75 mg Capsule Bottle Label)
Each capsule contains Nortriptyline. This is a prescription medication dispensed with an accompanying medication guide. The usual dosage should be as directed by a qualified medical practitioner. This product is stored at 20° to 25°C (68° to 77°F). It is a USP Controlled Room Temperature drug and therefore comes with child-resistant packaging. The capsules are equivalent to MID USP and produced by Taro Pharmaceutical Industries Ltd, in Israel. It is distributed by Taro Pharmaceuticals USA Inc., based in New York. The medication should be kept out of reach of children. Taro is a registered trademark.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.